Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 12
  • Journal CiteScore: 2.71
  • Journal Impact Factor: 2.30
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
Share This Page
Recommended Webinars & Conferences

13th World Congress on Breast Cancer Research & Therapies

Amsterdam, Netherlands

10th International Summit on Cancer Research and Diagnosis

Amsterdam, Netherlands

Abstract

Combined SPECT-CT Imaging in Breast Cancer

Karel Petrak

Radiopharmaceuticals utilized in standard atomic medication for patients with bosom malignancy are a notable wellspring of ionizing radiation, emitating gamma-photon particles: tumorotroponin cationic edifices like 99mTc-Sestamibi/Tetrofosmin (MIBI/TF); radiolabelled somatostatin analogs 111In-Ocrteoscan/99mTc-Tektrotyd; 99mTc-MDP; 99mTc-Nanocoll and so on The serious tracer take-up of the various radiopharmaceuticals relies upon the blood perfusion and their bio distribution, the proliferative movement of the tumor cells, the oxygen utilization, receptor status, and different elements of various tumors. For instance the tumorotroponin cation complex 99mTc-MIBI packs in the mitochondria while 99mTc-TF take-up is likewise in the cytosol, because of the reality, that in dynamic proliferative cells they are found in greater amount.